Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024

CORAL GABLES, Fla., May 01, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, de

Catalyst PharmaceuticalsMay 1 12:00

20 Companies Screened for Quality in a Cheap -2-

CarGurus Inc. Class A CARG 13.9% 0.0% 28.5% 4.8% 12.0% Inter

MarketWatchApr 27 18:25

Edgewise Gets EU Orphan Drug Status for Muscular Dystrophy Drug

Seeking AlphaApr 23 22:29

Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024

The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ETCORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Compa

Catalyst PharmaceuticalsApr 22 12:00

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Is Largely Controlled by Institutional Shareholders Who Own 65% of the Company

Yahoo FinanceApr 18 22:49

Jim Cramer's 10 Favorite Healthcare Stock Picks in 2024

Yahoo FinanceApr 14 00:18